Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial
Qin Tan(Nanjing Forestry University), Jie Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Fei Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingying Huang(Shanghai Institute of Nutrition and Health), Xueqing Hu(Beijing Hospital), Sen Qin(Peking University), Yifei Li(Tongji University), Yunbo Zhao(University of Science and Technology of China), Caixia Liu(Anhui University), Jinlian Tong(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiangyong Yu(Chinese Journal of Integrated Traditional and Western Medicine), Jing Xu(Shandong University of Technology)
Cited by 0
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea
|Nature Communications|2022|287